Print this page    •   Back to Web version of article

The ADAP Watch

December 17, 2010

As of December 16, 2010, there were 4,732 individuals on AIDS Drug Assistance Program (ADAP) waiting lists in 9 states. This is a 32 percent increase from the 3,586 individuals on the October 2010 ADAP Watch. Nineteen ADAPs, seven with current waiting lists, have instituted additional cost-containment measures since April 1, 2009 (reported as of December 9, 2010). In addition, 11 ADAPs, including four with current waiting lists, reported they are considering implementing new or additional cost-containment measures by the end of ADAP's current fiscal year (March 31, 2011).

States that have instituted cost containment measures and those considering them, in addition to implementing waiting lists, are reducing program financial and medical eligibility, capping enrollment, reducing the number of drugs on the formulary and cutting other services, all of which impact access to life saving HIV medications for medically vulnerable individuals.


ADAPs With Current or Anticipated Cost-Containment Measures, Including Waiting Lists, December 2010

ADAPs With Current or Anticipated Cost-Containment Measures, Including Waiting Lists, December 2010


ADAPs With Waiting Lists (4,732 Individuals in 9 States,* as of December 16, 2010)

Arkansas: 9 individuals
Florida: 2,491 individuals
Georgia: 845 individuals
Louisiana: 532 individuals**
Montana: 15 individuals
North Carolina: 87 individuals
Ohio: 380 individuals
South Carolina: 314 individuals
Virginia: 59 individuals


ADAPs With Other Cost-Containment Strategies (Instituted Since April 1, 2009, as of December 8, 2010)

Advertisement

Arizona: reduced formulary
Arkansas: reduced formulary, lowered financial eligibility to 200% FPL, disenrolled 99 clients in September 2009)
Colorado: reduced formulary
Florida: reduced formulary
Georgia: reduced formulary, implemented medical criteria, continued participation in the Alternative Method Demonstration Project (AMDP)
Idaho: capped enrollment
Illinois: reduced formulary, instituted monthly expenditure cap
Kentucky: reduced formulary
Louisiana: discontinued reimbursement of laboratory assays
New Jersey: reduced formulary
North Carolina: reduced formulary
North Dakota: capped enrollment, instituted annual expenditure cap, lowered financial eligibility to 300% FPL
Ohio: reduced formulary, lowered financial eligibility to 300% FPL (disenrolled 257 clients in July 2010)
Puerto Rico: reduced formulary
South Carolina: instituted annual expenditure cap, lowered financial eligibility to 300% FPL
Utah: reduced formulary, lowered financial eligibility to 250% FPL (disenrolled 89 clients in FY2010)
Virginia: reduced formulary
Washington: instituted client cost sharing, reduced formulary (for uninsured clients only)
Wyoming: capped enrollment, reduced formulary


ADAPs Considering New/Additional Cost-Containment Measures (Before March 31, 2011***)

Arizona: establish waiting list
Colorado: institute client cost sharing
Florida: lower financial eligibility to 300% FPL
Illinois: institute monthly expenditure cap, lower financial eligibility to 300% FPL
Ohio: disenroll approximately 861 clients based on new medical criteria
Oregon: reduce formulary
Puerto Rico: reduce formulary
South Carolina: disenroll 200 clients
Virginia: reduce formulary, transition 760 clients onto waiting list
Washington: establish waiting list, reduce formulary, cap enrollment, disenroll 500 clients
Wyoming: establish waiting list, reduce formulary

* As a result of ADAP emergency funding, Hawaii, Idaho, Iowa, Kentucky, South Dakota, and Utah eliminated their waiting lists.
** Louisiana has a capped enrollment on their program. This number is a representation of their current unmet need.
*** March 31, 2011 is the end of ADAP FY2010. ADAP fiscal years begin April 1 and end March 31.




This article was provided by National Alliance of State and Territorial AIDS Directors. You can find this article online by typing this address into your Web browser:
http://www.thebody.com/content/art59947.html

General Disclaimer: TheBody.com is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBody.com should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.